Qu S, Nelson H, Liu X, Wang Y, Semler E, Michell D
J Extracell Biol. 2024; 3(9):e70010.
PMID: 39281020
PMC: 11393769.
DOI: 10.1002/jex2.70010.
Shi X, Wang X, Yao W, Shi D, Shao X, Lu Z
Signal Transduct Target Ther. 2024; 9(1):192.
PMID: 39090094
PMC: 11294630.
DOI: 10.1038/s41392-024-01885-2.
Shaykevich A, Chae D, Silverman I, Bassali J, Louloueian N, Siegman A
Invest New Drugs. 2024; 42(2):229-239.
PMID: 38446332
PMC: 10944448.
DOI: 10.1007/s10637-024-01418-2.
Jimenez L, Barman B, Jung Y, Cocozza L, Krystofiak E, Saffold C
J Extracell Vesicles. 2023; 12(11):e12366.
PMID: 37885043
PMC: 10603024.
DOI: 10.1002/jev2.12366.
Lakhani A, Thompson S, Sheltzer J
Trends Genet. 2023; 39(12):968-980.
PMID: 37778926
PMC: 10715718.
DOI: 10.1016/j.tig.2023.09.002.
Proteomic Mapping of the Interactome of KRAS Mutants Identifies New Features of RAS Signalling Networks and the Mechanism of Action of Sotorasib.
Nolan A, Raso C, Kolch W, von Kriegsheim A, Wynne K, Matallanas D
Cancers (Basel). 2023; 15(16).
PMID: 37627169
PMC: 10452836.
DOI: 10.3390/cancers15164141.
Oncogene-like addiction to aneuploidy in human cancers.
Girish V, Lakhani A, Thompson S, Scaduto C, Brown L, Hagenson R
Science. 2023; 381(6660):eadg4521.
PMID: 37410869
PMC: 10753973.
DOI: 10.1126/science.adg4521.
Less demand on stem cell marker-positive cancer cells may characterize metastasis of colon cancer.
Kaida T, Fujiyama Y, Soeno T, Yokota M, Nakamoto S, Goto T
PLoS One. 2023; 18(4):e0277395.
PMID: 37098074
PMC: 10128954.
DOI: 10.1371/journal.pone.0277395.
Oncogene-like addiction to aneuploidy in human cancers.
Girish V, Lakhani A, Scaduto C, Thompson S, Brown L, Hagenson R
bioRxiv. 2023; .
PMID: 36711674
PMC: 9882055.
DOI: 10.1101/2023.01.09.523344.
Regulation of IFN-γ-mediated PD-L1 expression by MYC in colorectal cancer with wild-type KRAS and TP53 and its clinical implications.
Guo L, Tang X, Wong S, Guo A, Lin Y, Kwok H
Front Pharmacol. 2022; 13:1022129.
PMID: 36582540
PMC: 9792609.
DOI: 10.3389/fphar.2022.1022129.
Ursolic Acid Impairs Cellular Lipid Homeostasis and Lysosomal Membrane Integrity in Breast Carcinoma Cells.
Fogde D, Xavier C, Balnyte K, Holland L, Stahl-Meyer K, Dinant C
Cells. 2022; 11(24).
PMID: 36552844
PMC: 9776894.
DOI: 10.3390/cells11244079.
Zebrafish Avatars of rectal cancer patients validate the radiosensitive effect of metformin.
Costa B, Fernandez L, Pares O, Rio-Tinto R, Santiago I, Castillo-Martin M
Front Oncol. 2022; 12:862889.
PMID: 36249066
PMC: 9554544.
DOI: 10.3389/fonc.2022.862889.
Effect of deficiency and signaling on the bioenergetics of colon cancer cells in response to different substrates: A single cell study.
Kealey J, Dussmann H, Llorente-Folch I, Niewidok N, Salvucci M, Prehn J
Front Cell Dev Biol. 2022; 10:893677.
PMID: 36238683
PMC: 9550869.
DOI: 10.3389/fcell.2022.893677.
RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma.
East P, Kelly G, Biswas D, Marani M, Hancock D, Creasy T
Nat Commun. 2022; 13(1):5632.
PMID: 36163168
PMC: 9512813.
DOI: 10.1038/s41467-022-33290-0.
Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells.
Terado T, Kim C, Ushio A, Minami K, Tambe Y, Kageyama S
Int J Oncol. 2022; 61(3).
PMID: 35894141
PMC: 9339489.
DOI: 10.3892/ijo.2022.5398.
VAP-A and its binding partner CERT drive biogenesis of RNA-containing extracellular vesicles at ER membrane contact sites.
Barman B, Sung B, Krystofiak E, Ping J, Ramirez M, Millis B
Dev Cell. 2022; 57(8):974-994.e8.
PMID: 35421371
PMC: 9075344.
DOI: 10.1016/j.devcel.2022.03.012.
Pirin, an Nrf2-Regulated Protein, Is Overexpressed in Human Colorectal Tumors.
Zhang Y, Knatko E, Higgins M, Naidu S, Smith G, Honda T
Antioxidants (Basel). 2022; 11(2).
PMID: 35204145
PMC: 8868368.
DOI: 10.3390/antiox11020262.
Alternative polyadenylation is a determinant of oncogenic Ras function.
Subramanian A, Hall M, Hou H, Mufteev M, Yu B, Yuki K
Sci Adv. 2021; 7(51):eabh0562.
PMID: 34919436
PMC: 8682989.
DOI: 10.1126/sciadv.abh0562.
PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancer.
Jeung H, Puentes R, Aleshin A, Indarte M, Correa R, Bankston L
Exp Cell Res. 2021; 409(2):112930.
PMID: 34800542
PMC: 8925131.
DOI: 10.1016/j.yexcr.2021.112930.
CRISPR and KRAS: a match yet to be made.
Bender G, Fahrioglu Yamaci R, Taneri B
J Biomed Sci. 2021; 28(1):77.
PMID: 34781949
PMC: 8591907.
DOI: 10.1186/s12929-021-00772-0.